Catherine Kenny

Innovation and the Future of Pharmacovigilance

Send us a text

Ever wondered how a company navigates the complexities of Pharmacovigilance (PV)? Catherine Kenny, managing partner and co-founder of Signal Pharma Experts, takes us on an enlightening journey through it all. With years of experience spanning from a generics company to a director and head of Benefit Risk at Diamond Pharma Services, Catherine shares her invaluable insights into the intriguing world of PV.
Does the prospect of smaller firms utilizing AI, in the face of budgetary and resource limitations, seem daunting to you? Let’s take a look at it from a different angle. Imagine these firms joining forces to tackle larger safety database vendors - interesting, isn't it? Our discussion with Catherine brings in unique perspectives about managing regulatory inspections, project planning, and documentation. Plus, we emphasize on the oft-overlooked yet vital aspect of team spirit between departments in smaller firms.
Catherine unveils the realities of running a risk management department in a small company, underscoring the indispensability of real-world data, risk minimization, and signal detection. So buckle up for a thought-provoking conversation that uncovers a spectrum of insights into the world of PV.

บท

1. Catherine Kenny (00:00:00)

2. Exploring Careers in Pharmacovigilance (00:00:18)

3. AI Challenges in Small Companies (00:12:31)

4. QPPV Role and Challenges in Education (00:26:30)

5. Challenges and Considerations in Post-Marketing Activities (00:33:30)